Life Scientist > Biotechnology

Biota completes new flu trial

31 July, 2008 by Dylan Bushell-Embling

Phase II trials of long-acting compound conclude, Phase III next


Innovation review extended

31 July, 2008 by Kate McDonald

Deadline for Innovation Review green paper extended by a month


ASCC board sacks Livesey

31 July, 2008 by Kate McDonald

Stephen Livesey has "departed" the ASCC over difference with board


AtCor's pressure rises

30 July, 2008 by Dylan Bushell-Embling

Excellent sales results reported by AtCor


Lancet for Prana

30 July, 2008 by Dylan Bushell-Embling

Lancet Neurology publishes Prana's PBT2 trial results


Oncaidia's best practice

30 July, 2008 by Dylan Bushell-Embling

Oncaidia wins award Frost & Sullivan award for Apomab technology


Mayo specialist for Cytopia

30 July, 2008 by Dylan Bushell-Embling

Cytopia appoints clinical trial chair


Pond scum and the biofuel revolution

29 July, 2008 by Staff Writers

Murdoch Uni wins grant to research turning algae into energy


Heaves hit for Stirling

29 July, 2008 by Dylan Bushell-Embling

Stirling wins patent for equine heaves treatment


Clinuvel granted orphan designation

29 July, 2008 by Dylan Bushell-Embling

Clinuvel's CUV1647 granted orphan drug designation by US FDA


Tutti frutti for Kiwis

29 July, 2008 by Dylan Bushell-Embling

Large EST library for kiwifruit published, fleshing out apples and pears


Life to appeal Federal Court decision

29 July, 2008 by Dylan Bushell-Embling

Life Therapeutics to appeal federal court decision preventing its planned share sale


LCT is US-bound

29 July, 2008 by Dylan Bushell-Embling

Living Cell Technologies appoints new US-based CEO


CogState releases details of UBC agreement

29 July, 2008 by Dylan Bushell-Embling

Parties will combine to launch a new product but will remain separate entities


Biotech: worst year on record

29 July, 2008 by Kate McDonald

Final quarter of FY08 down again, year the worst on record: PwC


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd